Search

everythinglearnresearchcommunity

for

Search:↓

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Understanding hair follicle changes and hormones is key to diagnosing and treating hair loss.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

The research found that certain factors in hair follicle cells control hair growth and development, and these could be used to create new treatments for hair loss.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Idiopathic hirsutism might not be truly idiopathic but could be an early stage of hyperandrogenic disorders.

High androgen levels cause skin issues in PCOS, affecting quality of life.